Stock 6976 ACEPODIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Acepodia, Inc.

Equities

6976

KYG0073G1091

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
27.75 TWD -1.42% Intraday chart for Acepodia, Inc. +0.73% -18.74%
05-08 Acepodia Announces Preliminary Clinical Data From Phase 1 Clinical Trial of ACE1831, First-Ever Anti-CD20 Antibody Conjugated Allogenic Gamma Delta T Cell Therapy for Non-Hodgkins Lymphoma CI
02-06 US FDA OKs Acepodia's Investigational New Drug Application for Cancer Treatment MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Acepodia Announces Preliminary Clinical Data From Phase 1 Clinical Trial of ACE1831, First-Ever Anti-CD20 Antibody Conjugated Allogenic Gamma Delta T Cell Therapy for Non-Hodgkins Lymphoma
US FDA OKs Acepodia's Investigational New Drug Application for Cancer Treatment
Acepodia Biotech, Inc. Announces Clearance of Investigational New Drug Application by U.S. Food and Drug Administration for Investigational Product ACE2016
Acepodia, Inc.(TPEX:6976) added to S&P Global BMI Index
Acepodia Appoints Nobel Laureate Carolyn Bertozzi as Chief Scientific Advisor
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6976 Stock
  4. News Acepodia, Inc.
  5. Other languages